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Osteoporotic fractureThe region of chromosome 1q33–q54 harbors quantitative trait loci (QTL) for femur strength in COP×DA and
F344×LEW F2 rats. The purpose of this study is to identify the genes within this QTL region that contribute to
the variation in femur strength. Microarray analysis was performed using RNA extracted from femurs of COP,
DA, F344 and LEW rats. Genes differentially expressed in the 1q33–q54 region among these rat strains were
then ranked based on the strength of correlationwith femur strength in F2 animals derived from these rats. A
total of 214 genes in this QTL region were differentially expressed among all rat strains, and 81 genes were
found to be strongly correlated (r2N0.50) with femur strength. Of these, 12 candidate genes were prioritized
for further validation, and 8 of these genes (Iﬁt3, Ppp2r5b, Irf7, Mpeg1, Bloc1s2, Pycard, Sec23ip, and Hps6)
were conﬁrmed by quantitative PCR (qPCR). Ingenuity Pathway Analysis suggested that these genes were
involved in interferon alpha, nuclear factor-kappa B (NFkB), extracellular signal-related kinase (ERK),
hepatocyte nuclear factor 4 alpha (HNF4A) and tumor necrosis factor (TNF) pathways.
© 2009 Published by Elsevier Inc.Introduction
Osteoporosis is a common polygenic disorder characterized by
reduced bone mineral density (BMD) and compromised bone quality
with microarchitectural deterioration leading to an increased
susceptibility to fracture at multiple skeletal sites [1]. BMD, structure
and strength are the primary skeletal determinants of osteoporotic
fracture risk [2–4] and are under substantial genetic control [5–8].
Most of the studies identifying osteoporosis genes primarily focus on
BMD as it is the most commonly available tool for predicting fracture
risk. However, BMD is not an entirely adequate measure of bone
strength and structure. Bone strength, the phenotype that best
reﬂects skeletal fragility also depends on bone geometry (size and
shape), microarchitecture and material properties. Bone strength is
under the control of multiple genes, each of which has a modest
contribution to the genetic variance [15,20]. Identiﬁcation of genes
underlying bone strength will reveal valuable insight regarding the
genetics of osteoporosis and fracture risk.
Over many years, several linkage studies in human and experi-
mental animal models have identiﬁed quantitative trait loci (QTLs)
linked to bone structure and strength [9–21], but the genes underlying
these phenotypes are largely unknown. Identiﬁcation of candidatelsevier Inc.genes within the broad QTL intervals, which typically harbor hundreds
of genes, is extremely challenging and requires multiple complemen-
tary approaches. One strategy is the development of a congenic strain,
which can narrow the critical QTL to a small chromosomal segment
harboring fewer candidate genes. However, due to the extensive
breeding that is required, this approach is quite time-consuming and
expensive. Other approaches include creation of recombinant inbred
lines and haplotype-based analyses. However, these strategies do not
produce mapping with high enough resolution to detect the causal
genes. An alternative strategy involves an integrative genetic approach
combining linkage with genomic expression analysis in multiple
inbred lines already used for QTL analysis. Such studies are extremely
difﬁcult in humans, but they can be undertaken in animal models.
Previously, we showed that skeletal mass, structure and strength
vary among inbred strains of rats in a site-speciﬁc manner [22]. We
demonstrated that despite similar body size, substantial variation
exists in bone geometry and biomechanical properties between adult
Copenhagen 2331 (COP), Dark Agouti (DA), Fischer 344 (F344) and
Lewis (LEW) rats [22]. Subsequently, we generated a large number of
second ﬁlial (F2) female progeny derived from (COP×DA) and
(F344×LEW) crosses, and detected signiﬁcant linkage for femur
ultimate force (Fu) (a biomechanical measurement that determines the
maximum load that the bone can support before failing) within the
region of 1q33–q54 in both of these crosses [19,20]. Thus, 1q33–q54
region harbors QTLs for a bone phenotype directly related to femur
strength.
258 I. Alam et al. / Genomics 94 (2009) 257–262The purpose of this study was to narrow the list of candidate
genes within the region of 1q33–q54 contributing to the variation
in femur strength among COP, DA, F344 and LEW rats. We chose
these strains of rats because, at present, these are the only available
rat models in which bone QTLs have been identiﬁed [18–21]. We
used the data from microarray-based gene expression analyses to
identify genes differentially expressed among these rats. These
genes were then ranked based on their correlation with Fu in F2
animals derived from these rat strains. The expression levels of
several strongly correlated (r2N0.9) candidate genes were con-
ﬁrmed using quantitative real-time PCR (qPCR). In addition, we
applied Ingenuity Pathway Analysis (IPA) for analysis of the related
pathways among prioritized candidate genes based on their mole-
cular function, biological process and cellular component of the
gene products. IPA is a structured, network-based system to analyze
genome-wide gene expression in the context of known functional
interrelationships among genes, proteins, and small molecules. This
approach has been successfully used for various systems including
bone [35,36].
Results
Genetic loci for femur Fu on 1q33–q54
Evidence of signiﬁcant linkage of femur Fu was detected in the
region of 1q33–q54 in COP×DA F2 animals with LOD scores of 6.7
(Fig. 1) [19]. In addition, signiﬁcant evidence of linkage of femur
Fu was observed in F344×LEW F2 rats with a LOD score of 4.8, in
a broad region that overlapped the COP×DA peak (Fig. 1) [20].
Femur Fu as a function of genotypes
Genotypic means for femur Fu was measured on Chr 1 at D1Rat69
(101.5 cM) in the COP×DA F2 rats and at D1Rat291 (101.4 cM) in the
F344×LEW F2 rats. Since a QTLwas detected atmarker D1Rat69 in the
COP×DA cross and at marker D1Rat291 in the F344×LEW cross, the
mean values for the femur Fu were signiﬁcantly different between the
F2 animals homozygous for the COP (c/c) and the DA (d/d) F2 alleles
(120.35±1.81 vs. 129.08±1.87; p=0.001) and the F2 animals homo-
zygous for the F344 (f/f) and LEW (l/l) F2 alleles (130.47±1.11 vs.
138.02±1.08; pb0.0001).Fig. 1. Linkage analysis for femur ultimate force (Fu) for rat chromosome 1 in COP×DA
and F344×LEW crosses in the region of 1q33–q54 (D1Rat52–D1Rat82). LOD scores
plotted on the y axis vs. the relative microsatellite markers located along chromosome 1
on the x axis.Microarray analyses and correlation with femur phenotypes
The Affymetrix microarray analyses showed that a total of 214
genes residing in the region of 1q33–q54 (among the 999 total genes
on the microarray probe sets) were differentially expressed among
COP, DA, F344 and LEW rats with a FDR less than 10%. Regression
analyses were performed for all 214 differentially expressed genes to
assess the correlation between gene expression and the femur Fu
among F2 animals homozygous for that strain's allele at the markers
(D1Rat69 for COP×DA; D1Rat291 for F344×LEW) underlying the
QTL. The 1q33–q54 QTL for Fu was replicated in both (COP×DA) and
(F344×LEW) crosses; therefore, we identiﬁed candidate genes that
showed strong correlation (r2N0.50) for this phenotype in these
rats. We considered any r-value of above 0.7, which corresponds to
a r2-value of above 0.49, as a strong correlation. A total of 81 genes,
including 72 candidate genes and 9 predicted genes (Supplementary
Table 1), were detected using this method. Among these 72 genes,
12 were ranked as the highest priority because they were found to
explain more than 90% (r2N0.90) of the variation of femur Fu
(Supplementary Table 1).
qPCR analyses
qPCR analyses of the 12 prioritized candidate genes in Supple-
mentary Table 1 conﬁrmed the strong correlation between gene
expression and femur ultimate force (Table 1). The correlation
coefﬁcients for Pold4, Iﬁt3, Hps6, Mrpl3, Map4k2, Sec23ip, Rras2,
Pycard, Ppp2r5b, Irf7, Mpeg1 and Bloc1s2 between microarray and
qPCR analyses were 0.65, 0.99, 0.70, 0.70, 0.24, 0.81, 0.22, 0.94, 0.96,
0.99, 0.94 and 0.89, respectively, indicating good concordance
between the two methods for all genes except Map4k2 and Rras2.
Among these 12 candidate genes, 8 genes (Iﬁt3, Ppp2r5b, Irf7,
Mpeg1, Bloc1s2, Pycard, Sec23ip and Hps6) were conﬁrmed to have
similar correlations with femur strength by qPCR (r2-values ranging
from 0.59 to 0.97) (Table 1).
Pathway analysis
The 8 candidate genes that were conﬁrmed by qPCR were mapped
to pathways using Ingenuity Pathway Analysis. These genes were
directly or indirectly connected to interferon alpha, nuclear factor-
kappa B (NFkB), extracellular signal-related kinase (ERK), hepatocyte
nuclear factor 4 alpha (HNF4A) and tumor necrosis factor (TNF)
pathways (Fig. 2).
Discussion
Genetic mapping for complex traits usually identiﬁes chromoso-
mal regions that are typically quite broad in nature. The 1q33–q54 QTL
region linked to various femur phenotypes also encompasses a broad
region of roughly 60 cM of the rat genome, harboring nearly 1000
genes. In addition, many of these genes might have pleiotropic effects
on different femur phenotypes. Also, there might be a cluster of genes
contributing individually to these phenotypes. To prioritize candidate
genes for further analysis, we employed an integrative genetic
approach combining linkage, gene expression and physical traits.
We took the advantage of microarray-based expression analyses to
simultaneously screen thousands of genes for their differential
expression in COP, DA, F344 and LEW rats, as these are the only
available rat models in which bone QTLs have been identiﬁed [18–21].
In addition, we used 4-week-old rats for gene expression analyses
since we wanted to assess gene regulation of bone accrual and to
identify genes contribute to the accumulation of peak bone mass. By
comparing the genes differentially expressed among these rats, we
were able to signiﬁcantly reduce the number of candidate genes in the
1q33–q54 QTL region to 214.
Table 1
r-square values from qPCR analysis of top 12 candidate genes for femur ultimate force










Iﬁt3 Interferon-induced protein with
tetratricopeptide repeats 3
0.97 1q52 10q23.3
Ppp2r5b Protein phosphatase 2, regulatory
subunit B, delta isoform
0.85 1q43 11q13
Irf7 Interferon regulatory factor 7 0.88 1q41 11p15.5
Mpeg1 Macrophage expressed gene 1 0.72 1q43 11q12.1
Bloc1s2 Biogenesis of lysosome-related
organelles complex-1, subunit 2
0.74 1q54 10q24.31
Pycard PYD and CARD domain containing 0.65 1q36 16p12
Sec23ip SEC23 interacting protein 0.61 1q37 10q26.11
Hps6 Hermansky–Pudlak syndrome 6 0.59 1q54 10q24.3
Pold4 Polymerase (DNA-directed), delta 4 0.45 1q42 11q13.1
Mrpl43 Mitochondrial ribosomal protein L43 0.34 1q54 10q24.31
Rras2 Related RAS viral (r-ras) oncogene
homolog 2
0.24 1q34 11p15.2
Map4k2 Mitogen activated protein kinase
kinase kinase kinase 2
0.20 1q43 11q13
a Conﬁrmed genes (r2N0.50) are indicated in bold face.
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by ranking the genes for the magnitude of expression differences
(fold-differences) between different strains. However, with complex
traits like osteoporosis, even subtle changes in gene expression could
be important. Thus, stronger evidence for the association between a
gene and a trait might be identiﬁed by examining the correlation
between gene expression and a given physical trait. Using thisFig. 2. Network of the 8 candidate genes that were conﬁrmed by qPCR (highlighted in red) f
TNF pathways related to bone metabolism is highlighted in blue.approach, among the 214 candidate genes, we were able to prioritize
72 genes that were strongly correlated (r2N0.5) with femur strength.
Furthermore, by investigating genes those were correlated with more
than 90% variation (r2N0.9) with femur ultimate force, we further
narrowed the list of genes to 12 candidate (Supplementary Table 1).
Among these 12 candidate genes, 8 genes (Iﬁt3, Ppp2r5b, Irf7,
Mpeg1, Bloc1s2, Pycard, Sec23ip and Hps6) were conﬁrmed to have
similar strong correlations (r2-values ranging from 0.59 to 0.97) with
the femur strength when expressionwas measured by qPCR (Table 1).
Surprisingly, four genes (Pold4, Mrpl43, Map4k2 and Rras2) that
showed high correlations for femur strength by Affymetrix analysis
were not conﬁrmed by qPCR; the difference may relate to probe
location for the arrays at the 3′ end of the target gene. The 8 candidate
genes that were conﬁrmed by qPCR were associated with pathways
directly or indirectly involved in controlling cell morphology and
development, cellular assembly and organization, cell-to-cell signal-
ing, molecular transport, protein trafﬁcking, and cellular function and
maintenance (Fig. 2). Genes in the canonical pathways (networks
generated using IPA) were related to interferon signaling and activa-
tion of pattern recognition receptors. When these genes were catego-
rized based on location of cellular components Iﬁt3, Mpeg1, Bloc1s2,
Pycard, Sec23ip and Hps6 are located in cytoplasm while Ppp2r5b and
Irf7 are located in the nucleus. Recently, signaling networks with
interferon and other cytokines have been shown to be important in
bone metabolism [30]. Interestingly, the top 2 candidate genes (Iﬁt3
and Irf7) identiﬁed in this study are interferon-related genes and
pathwayanalysis revealed several interferonmolecules involved in the
same network (Fig. 2). Interferon regulatory factors Irf1 and Irf2 have
been associated with osteoblast apoptosis [37] but roles for Iﬁt3 and
Irf7 in bone biology have not yet been studied. However, bothor femur strength in Ingenuity Pathway Analysis (IPA). The well-known NFkB, ERK and
260 I. Alam et al. / Genomics 94 (2009) 257–262interferon alpha and beta signaling has been shown to be important for
maintaining normal bone mass by regulating osteoclastic bone
resorption [38]. Interferon receptor alpha 1 knockout mice exhibit an
osteoporosis phenotype due to increased osteoclastogenesis and
decreased trabecular bonemass. Interferon-beta inhibits RANK-ligand
mediated osteoclastogenesis by inhibiting the expression of c-FOS and
mice lacking interferon-beta have severe osteopenia due to enhanced
osteoclastogenesis [38]. In addition, Ppp2r5b (Ppp2r2d) has been pre-
viously shown to have role in TGF-beta signaling [27] and Pycard is a
regulator of NFkB activation pathway [28]. Hps6 is associated with
Hermansky–Pudlak syndrome, an autosomal recessive syndrome due
to a mutation in clathrin-associated adaptor protein [32]. Because
clathrin is important in the WNT signaling pathway in bone [33],
Hps6 might be involved in the molecular regulation of the WNT
pathway. Bloc1s2 has been shown to regulate apoptosis in cancer
[31], and Sec23ip is involved in protein export from the endoplasmic
reticulum [34], and both of these genes are indirectly related to
Hps5/6 genes. In a recent study, Sec23ip has been shown to be
essential for normal craniofacial development [39]. The candidate
genes and the interconnected molecules identiﬁed in this study are
thus related to pathways involving both bone formation and resorp-
tion: nuclear factor-kappa B (NFkB) regulates osteoclast mediated
bone resorption [40,41]; extracellular signal-related kinase (ERK) has
critical role in osteoblast differentiation and bone development [42] as
well as osteoclast differentiation and survival [43]; members of tumor
necrosis factor (TNF) family of ligands and receptors are critical
regulators of osteoclastogenesis [44,45]. However, further functional
analysis using gene targeting strategies such as knockout and siRNA
will be necessary to fully characterize the roles of these candidate
genes in bone metabolism.
The chromosomal region of the candidate genes for femur
strength on Chr 1 in rats is homologous to regions of mouse
chromosomes 7, 19 and human chromosomes 10q, 11p, 11q, and 16p
(Table 1). Linkage to mouse Chr 7 was previously reported for femur
strength and structure [16–17]. Furthermore, the homologous
regions in human 10q21, 10q26 and 11p15 were previously linked
to wrist bone size, hip BMD and spine bone size, respectively
[12,13,29].
In this study, using an integrative genetic approach, we identiﬁed
several top candidate genes underlying the QTL region of 1q33–q54
that were differentially expressed and strongly correlated with femur
strength in rats. The approach we took here is complementary to
conventional strategies for the dissection of complex traits and will
facilitate the QTL to gene discovery process. However our approach
has several limitations. Gene expression study based on microarray
analysis explains only transcriptional regulation of genes and does not
capture effects of alternative gene splicing or post-translational
modiﬁcation of proteins. In addition, the whole femur RNA came
from a variety of different types of bone cells including bone marrow
and thus we cannot be sure that the gene expression changes
originated only from bone cells. Further studies involving different cell
lines are thus necessary to identify which speciﬁc cell type expresses
the genes identiﬁed in this study. Also, our results could be inﬂuenced
by the genetic contributions from other QTLs from the same or other
chromosomes. Some of these problems could be solved by isolating
the Chr 1 QTL region from the effects of other QTLs throughout the
genome by using congenic rats. Also, whether the same candidate
genes regulate femur strength in male rats remains to be determined,
as we only studied female rats in this study.
Materials and methods
In previous studies, we created 423 and 595 female 2nd ﬁlial (F2)
offspring from COP×DA and F344×LEW crosses, respectively. The rats
were allowed to grow to 6 months (26 weeks) of age before sacriﬁce.
The lower limbs and spleen were dissected out. The right side of thelower limbs were immediately stored at −20 °C for biomechanical
analysis. The spleens were immediately frozen in liquid nitrogen
before transferring them to −80 °C. The right femurs were tested in
three-point bending by positioning them on the lower supports of a
three-point bending ﬁxture and applying load at the midpoint using a
material testing machine (Alliance RT/5, MTS Systems Corp., Eden
Prairie, MN, USA) and ultimate force (Fu; N) was obtained from the
force vs. displacement curves in TestWorks software, version 4.06 as
described previously [19,20].
Genotyping for each animal was accomplished with microsatel-
lite markers using genomic DNA isolated from spleen previously
shown to be polymorphic for COP, DA, F344 and LEW rats with an
average interval of 20 cM from centromere to telomere. Chromo-
somal positions, marker order, and map positions were obtained
from the Rat Genome Database (RGD) website (http://rgd.mcw.
edu/). Genotypic data in the F2 animals for each marker were
tested to ensure the expected Mendelian ratios. Marker maps were
generated using MAPMARKER/EXP with data from all available
genotyped F2 animals. Multipoint quantitative linkage analysis was
then performed to identify chromosomal regions that harbor QTL for
femur Fu using the programs R/qtl and QTL/Cartographer. Permuta-
tion testing was employed to obtain appropriate genome-wide
signiﬁcance levels for the linkage results and ANOVA was used for
the most signiﬁcant marker in each QTL region to further charac-
terize signiﬁcant genotypic group differences as described pre-
viously [19,20].
RNA extraction and microarray analysis
Whole femora were harvested from 4-week-old COP, DA, F344
and LEW animals and were immediately frozen in liquid nitrogen
and stored at −80 °C until required. RNA from femurs was extracted
from 4 animals per strain using Trizol (Invitrogen, Carlsbad, CA),
followed by further puriﬁcation using an RNeasy Mini Kit (Qiagen
Inc., Valencia, CA) as described previously [23]. RNA quality was
determined using a 2100 Bioanalyzer (Agilent, Palo Alto, CA) and
was quantiﬁed using a spectrophotometer (NanoDrop, Wilmington,
DE, USA). For microarray analysis, 5 μg of total RNA from each
sample was labeled and hybridized to Affymetrix Rat Genome 230
2.0 GeneChips (Affymetrix, Santa Clara, CA) as described previously
[23]. Quality control for RNA and Affymetrix data was done as
described previously [23].
Microarray data analysis and informatics
The images from each array were analyzed using Affymetrix
GeneChip Operating system (GCOS) 1.2 software. Mapping of probe
sets to chromosomal location was accomplished with data provided
by Affymetrix. The region of 1q33–q54, limited by the markers of
D1Rat52 (80.1 cM) and D1Rat82 (139.0 cM), harbors a total of 999
genes. Among these genes, the identities of the 214 differentially
expressed genes within this QTL region were conﬁrmed by com-
paring the target mRNA sequences on the Affymetrix Rat Genome
230 2.0 GeneChip with the National Center for Biotechnology
Information (NCBI) GenBank database (http://www.ncbi.nlm.nih.
gov/Genbank/). To increase power and decrease the false discovery
rate (FDR), we only analyzed probe sets that were reliably detected
on all of the microarrays, based upon the detection call generated by
the Affymetrix Microarray Analysis Suite 5.0 algorithm [25]. FDR was
calculated by the method of Benjamini and Hochberg [26]. Probe sets
were considered differentially expressed if the FDR was less than
10%. We used 10% FDR because we wanted to reduce the number of
false negatives when we identiﬁed differentially expressed genes.
The microarray data set was submitted to the NCBI Gene Expression
Omnibus (GEO) Express web portal (GEO accession number
GSE 11180).
261I. Alam et al. / Genomics 94 (2009) 257–262Quantitative real-time PCR (qPCR) analysis
Five micrograms of total RNA (the same RNA used for Affymetrix
analysis) was reverse transcribed using Superscript III reverse
transcription reagent for ﬁrst-strand cDNA synthesis (Invitrogen,
CA). Twelve strongly correlated (r2N0.90) candidate genes for femur
Fu were selected for veriﬁcation of microarray data by qPCR analysis.
All real-time PCR reactions contained the ﬁrst-strand cDNA corre-
sponding to 25 ng of total RNA. Real-time detection of PCR products
was performed using ABI PRISM 7300 sequence detector (Applied
Biosystem, CA) as described previously [23]. Expression of mRNAwas
calculated based on a relative standard curve and normalized to
beta-actin. All qPCR analysis used triplicates of each of 4 biological
samples.
Statistics
Differential expression of each gene among all strains was
calculated by ANOVA using the package Limma [24]. Regression
analysis was performedwith the average gene expression level for the
strain as the dependent variable, and the phenotypic mean value of
femur Fu in animals homozygous for that strain's allele at the marker
underlying the QTL as the independent variable. The proportion of
variation (r2-value) in the phenotypic means explained by the
variation in gene expression was obtained using the statistical
software package StatView (Abacus Concepts, Inc., Berkeley, CA).
Pathway analysis
The interactions between differentially expressed genes conﬁrmed
by qPCR for femur strength and all other genes were investigated
using Ingenuity Pathway Analysis (IPA 5.0; Ingenuity Systems, Inc.,
Mountain View, CA). The differentially expressed genes were
uploaded into the application. Each gene identiﬁer was mapped to
its corresponding gene in the Ingenuity Pathway Knowledge Base
(IPKB). These genes were overlaid onto a global network developed
from the information contained in the IPKB. Networks of these genes,
deﬁned as the reﬂection of all interactions of a given gene deﬁned in
the literature, were then algorithmically generated based on their
connectivity. The interactions indicate physical association, induction/
activation or repression/inactivation of one gene product by the other,
directly or through another intermediary molecule.
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